Mountain Hospice, Inc. 1002 South Crim Avenue, Belington, WV, 26250 | |
(304) 823-3922 |
News Archive
World leaders today signalled an unprecedented level of attention to curb the spread of infections that are resistant to antimicrobial medicines.
BioCryst Pharmaceuticals, Inc. announced favorable 52-week safety results and sustained efficacy from the extension phase of its randomized Phase 2b trial of ulodesine (BCX4208) added to allopurinol in patients with gout who had failed to reach the serum uric acid (sUA) therapeutic goal of <6 mg/dL on allopurinol alone, as well as positive Phase 2 safety results in patients with mild to moderate renal impairment.
The Washington Post examines the influence of commercial interests on the "political declaration" that emerged from this week's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York. NCDs "are the globe's biggest health problem, responsible for 63 percent of all deaths each year, with incidence growing steeply in the low-income, rapidly urbanizing nations of the world," but they "are deeply entangled with important global industries, not only tobacco but also food, pharmaceuticals, advertising, transportation and construction," the newspaper writes.
A new study by Narendra et al. suggests that Parkin, the product of the Parkinson's disease-related gene Park2, prompts neuronal survival by clearing the cell of its damaged mitochondria.
New research reveals the shape of our brain can provide surprising clues about how we behave and our risk of developing mental health disorders.
› Verified 2 days ago
Name | Mountain Hospice, Inc. |
---|---|
Location | 1002 South Crim Avenue, Belington, West Virginia |
Hospice ID | 511514 |
Category | Freestanding Hospice |
Ownership Type | Voluntary Non-profit - Other |
Profit Type | NON-PROFIT |
SSA county code | 000 |
News Archive
World leaders today signalled an unprecedented level of attention to curb the spread of infections that are resistant to antimicrobial medicines.
BioCryst Pharmaceuticals, Inc. announced favorable 52-week safety results and sustained efficacy from the extension phase of its randomized Phase 2b trial of ulodesine (BCX4208) added to allopurinol in patients with gout who had failed to reach the serum uric acid (sUA) therapeutic goal of <6 mg/dL on allopurinol alone, as well as positive Phase 2 safety results in patients with mild to moderate renal impairment.
The Washington Post examines the influence of commercial interests on the "political declaration" that emerged from this week's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York. NCDs "are the globe's biggest health problem, responsible for 63 percent of all deaths each year, with incidence growing steeply in the low-income, rapidly urbanizing nations of the world," but they "are deeply entangled with important global industries, not only tobacco but also food, pharmaceuticals, advertising, transportation and construction," the newspaper writes.
A new study by Narendra et al. suggests that Parkin, the product of the Parkinson's disease-related gene Park2, prompts neuronal survival by clearing the cell of its damaged mitochondria.
New research reveals the shape of our brain can provide surprising clues about how we behave and our risk of developing mental health disorders.
› Verified 2 days ago
NPI Number | 1548253735 |
Organization Name | Mountain Hospice Inc |
Address | 1002 S Crim Ave Belington, West Virginia, 26250 |
Phone Number | (304)823-3922 |
News Archive
World leaders today signalled an unprecedented level of attention to curb the spread of infections that are resistant to antimicrobial medicines.
BioCryst Pharmaceuticals, Inc. announced favorable 52-week safety results and sustained efficacy from the extension phase of its randomized Phase 2b trial of ulodesine (BCX4208) added to allopurinol in patients with gout who had failed to reach the serum uric acid (sUA) therapeutic goal of <6 mg/dL on allopurinol alone, as well as positive Phase 2 safety results in patients with mild to moderate renal impairment.
The Washington Post examines the influence of commercial interests on the "political declaration" that emerged from this week's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York. NCDs "are the globe's biggest health problem, responsible for 63 percent of all deaths each year, with incidence growing steeply in the low-income, rapidly urbanizing nations of the world," but they "are deeply entangled with important global industries, not only tobacco but also food, pharmaceuticals, advertising, transportation and construction," the newspaper writes.
A new study by Narendra et al. suggests that Parkin, the product of the Parkinson's disease-related gene Park2, prompts neuronal survival by clearing the cell of its damaged mitochondria.
New research reveals the shape of our brain can provide surprising clues about how we behave and our risk of developing mental health disorders.
› Verified 2 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 86.2 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 76.5 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 96.6 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 72.6 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 99.3 | 97.3 |
Patients who got timely treatment for shortness of breath | 82.5 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 87.9 | 93.3 |
News Archive
World leaders today signalled an unprecedented level of attention to curb the spread of infections that are resistant to antimicrobial medicines.
BioCryst Pharmaceuticals, Inc. announced favorable 52-week safety results and sustained efficacy from the extension phase of its randomized Phase 2b trial of ulodesine (BCX4208) added to allopurinol in patients with gout who had failed to reach the serum uric acid (sUA) therapeutic goal of <6 mg/dL on allopurinol alone, as well as positive Phase 2 safety results in patients with mild to moderate renal impairment.
The Washington Post examines the influence of commercial interests on the "political declaration" that emerged from this week's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York. NCDs "are the globe's biggest health problem, responsible for 63 percent of all deaths each year, with incidence growing steeply in the low-income, rapidly urbanizing nations of the world," but they "are deeply entangled with important global industries, not only tobacco but also food, pharmaceuticals, advertising, transportation and construction," the newspaper writes.
A new study by Narendra et al. suggests that Parkin, the product of the Parkinson's disease-related gene Park2, prompts neuronal survival by clearing the cell of its damaged mitochondria.
New research reveals the shape of our brain can provide surprising clues about how we behave and our risk of developing mental health disorders.
› Verified 2 days ago
Home Health Aides | 13 |
Counselors | 1 |
Licensed Practical or Vocational Nurses | 5 |
Medical Social Workers | 4 |
Physicians | 1 |
Registered Nurses | 10 |
Other Personnel | 15 |
Total Employees | 49 |
---|
News Archive
World leaders today signalled an unprecedented level of attention to curb the spread of infections that are resistant to antimicrobial medicines.
BioCryst Pharmaceuticals, Inc. announced favorable 52-week safety results and sustained efficacy from the extension phase of its randomized Phase 2b trial of ulodesine (BCX4208) added to allopurinol in patients with gout who had failed to reach the serum uric acid (sUA) therapeutic goal of <6 mg/dL on allopurinol alone, as well as positive Phase 2 safety results in patients with mild to moderate renal impairment.
The Washington Post examines the influence of commercial interests on the "political declaration" that emerged from this week's U.N. High-level Meeting on Non-Communicable Diseases (NCDs) in New York. NCDs "are the globe's biggest health problem, responsible for 63 percent of all deaths each year, with incidence growing steeply in the low-income, rapidly urbanizing nations of the world," but they "are deeply entangled with important global industries, not only tobacco but also food, pharmaceuticals, advertising, transportation and construction," the newspaper writes.
A new study by Narendra et al. suggests that Parkin, the product of the Parkinson's disease-related gene Park2, prompts neuronal survival by clearing the cell of its damaged mitochondria.
New research reveals the shape of our brain can provide surprising clues about how we behave and our risk of developing mental health disorders.
› Verified 2 days ago
Mountain Hospice, Inc. Location: 1002 South Crim Avenue, Belington, West Virginia, 26250 Phone: (304) 823-3922 |